Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07135895 · ClinicalTrials.gov registry record · NA
The ArtixASCEND Study
A NA study of Acute Lower Limb Arterial Occlusion, sponsored by Inari Medical.
- Recruiting
- Registry status
- NA
- Development phase
- 250
- Enrollment target
- 5
- Study locations
NCT07135895: Recruiting NA study of Acute Lower Limb Arterial Occlusion, sponsored by Inari Medical.
NCT07135895 is a NA study of Acute Lower Limb Arterial Occlusion that is actively recruiting participants, run by Inari Medical. The registered enrollment target is 250 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07135895, a NA study of Acute Lower Limb Arterial Occlusion, is actively recruiting participants, sponsored by Inari Medical.
- RECRUITING
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
- 5
- Study locations
Study Summary
This study is a post-market, prospective, multicenter, single-arm study to evaluate the safety and effectiveness of the Artix Thrombectomy System in patients with acute lower extremity arterial occlusions.
Primary Outcome
Revascularization rate post-index procedure of target treatment area determined by an independent core lab.
Conditions Studied
Interventions
- DEVICE Artix Thrombectomy System
Study Locations (5)
Connecticut
- Yale University - New Haven
District of Columbia
- MedStar Washington Hospital Center - Washington D.C.
North Carolina
- Mission Memorial Hospital - Asheville
Oklahoma
- Ascension St. John Jane Phillips Medical Center - Bartlesville
South Carolina
- Grand Strand Medical Center - Myrtle Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2026-01-07 |
| Est. Completion | 2029-10-01 |
| Phase | NA |
What NCT07135895 shows while recruiting
NCT07135895 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).
The record links to 1 condition, with Acute Lower Limb Arterial Occlusion appearing as the primary indexed condition, and to 1 intervention - of which Artix Thrombectomy System is the first listed.
NCT07135895 lists 5 locations in 5 states (Connecticut, District of Columbia, North Carolina).
Frequently Asked Questions
What is clinical trial NCT07135895 about?
NCT07135895 is a clinical study titled "The ArtixASCEND Study". This study is a post-market, prospective, multicenter, single-arm study to evaluate the safety and effectiveness of the Artix Thrombectomy System in patients with acute lower extremity arterial occlusions.
What is the current status of trial NCT07135895?
This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2026-01-07. Estimated completion is 2029-10-01.
What conditions does trial NCT07135895 study?
This clinical trial studies the following conditions: Acute Lower Limb Arterial Occlusion.
What interventions are being tested in trial NCT07135895?
The interventions under investigation include: Artix Thrombectomy System (DEVICE).
Who is sponsoring clinical trial NCT07135895?
This trial is sponsored by Inari Medical, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07135895 being conducted?
This trial has 5 study locations across Connecticut, District of Columbia, North Carolina, Oklahoma, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07135895's enrollment target sits among peer trials
250 410th of 2000 higher than 1,567 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI